본문으로 건너뛰기
ProhibitedBinding ruleGBOriginal is English공식 출처 가져오기 확인됨

1,3-Dimethylpentylamine and its salts

The consolidated GB Cosmetics Regulation lists this record in Annex II.

규제 판단 및 전체 조건

상태
Prohibited
법적 역할
Binding rule
규제 요약
The consolidated GB Cosmetics Regulation lists this record in Annex II.
조건 및 제한 사항
A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. 인용된 출처를 열고 아래의 시장 전체 요건을 적용하세요.

물질 정체

공식 출처상의 명칭
1,3-Dimethylpentylamine and its salts
CAS
105-41-9
EC
203-296-1
정체 매핑
standalone:official_gb_annex

이 정체의 시장 간 요약

현재 이 사이트에 있는 정확히 연결된 기록입니다. 시장이 없는 것은 가져온 정확한 일치 항목이 없다는 뜻이며, 해당 물질의 사용이 허용된다는 뜻이 아닙니다.

시장 데이터세트 10개

South Korea

Prohibited

연결된 기록 1건 · 특정 조건이 있는 기록 1건

보조 기록 열기
CAS 105-41-9의 PubChem 2D 화학 구조
CAS 105-41-9PubChem CID 7753

CAS 105-41-9의 검증된 화학 정보

1,3-Dimethylamylamine

Methylhexaneamine is an alkylamine. — ChEBI

IUPAC 명칭
4-methylhexan-2-amine
분자식
C7H17N
분자량
115.22 g/mol
정확한 질량
115.136099547 Da
단일 동위원소 질량
115.136099547 Da
XLogP3
1.9
위상 극성 표면적
26.0 Ų
분자 복잡도
52.0
형식 전하
0
수소 결합 공여체
1
수소 결합 수용체
1
회전 가능 결합
3
중원자
8
공유결합 단위
1

PubChem에 보고된 명칭 및 동의어

1,3-DimethylpentylamineMethylhexaneamineForthane2-Amino-4-methylhexane4-Methyl-2-hexanamineForthan4-Methyl-2-hexylamineDimethylamylamine
보고된 명칭 16개 더 보기
Geranaminefloradrene1,3-DMAAX49C572YQONSC-1106RefChem:818621203-296-1Methylhexanamine2-Hexanamine, 4-methyl-NSC 1106PENTYLAMINE, 1,3-DIMETHYL-AI3-16556EINECS 203-296-1DMAA [Dietary Supplement]BRN 1731697UNII-X49C572YQO
외부 데이터베이스 식별자
고급 구조 통계
정의된 원자 입체중심
0
정의되지 않은 원자 입체중심
2
정의된 결합 입체중심
0
정의되지 않은 결합 입체중심
0
3D 파마코포어 특성
4
3D 고리
0
3D 소수성 부위
2
3D 수용체 특성
0
3D 공여체 특성
1
3D 음이온 중심
0
3D 양이온 중심
1
3D 형태이성질체
10
유효 3D 회전자
3.0
기계 판독 가능한 구조 식별자
SMILES
CCC(C)CC(C)N
InChI
InChI=1S/C7H17N/c1-4-6(2)5-7(3)8/h6-7H,4-5,8H2,1-3H3
InChIKey
YAHRDLICUYEDAU-UHFFFAOYSA-N

추가 과학 데이터베이스의 근거

EMBL-EBI ChEBI
식별자 정확히 일치CHEBI:134754

methylhexaneamine

처방
C7H17N
평균 질량
115.220 g/mol
단일 동위원소 질량
115.13610 Da
형식 전하
0
  • alkylamine — is a (CHEBI:13759)
  • alkylamine — is a (CHEBI:13759)
추가 선별 명칭
1,3-dimethylpentylamine2-amino-4-methylhexane4-methyl-2-hexylamineforthanforthane
이 출처의 상호 참조
  • CAS: 105-41-9 — DrugCentral
  • MANUAL_X_REF: 3353 — DrugCentral

매핑 기준: Exact CAS cross-reference in the ChEBI compound record. 출처 업데이트: 2017-02-23. 가져온 시각: 2026-08-31. 출처 기록 열기

NIH PubChem PUG-View
식별자 정확히 일치7753

Attributed physical-property, hazard, environmental and use annotations.

  • Signal: Danger 출처: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H226 (100%): Flammable liquid and vapor [Warning Flammable liquids]; H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] 출처: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P210, P233, P240, P241, P242, P243, P260, P261, P264, P270, P271, P280, P301+P317, P301+P330+P331, P302+P361+P354, P303+P361+P353, P304+P340, P305+P354+P338, P316, P319, P321, P330, P363, P370+P378, P403+P233, P403+P235, P405, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
  • Environmental Bioconcentration: An estimated BCF of 12 was calculated in fish for 1,3-dimethylamylamine(SRC), using an estimated log Kow of 2.16(1) and a regression-derived equation(1). According to a classification scheme(2), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 200(SRC), determined from a structure estimation method(2), indicates that 1,3-dimethylamylamine is expected to have moderate mobility in soil(SRC). The pKa of 1,3-dimethylamylamine is estimated to be 10.6(SRC) based on analogy to similar amines(3), indicating that this compound will exist primarily in cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4). Volatilization of 1,3-dimethylamylamine from moist soil surfaces may occur(SRC) given an estimated Henry's Law constant of 4.2X10-5 atm-cu m/mole(SRC), using a fragment constant estimation method(2). 1,3-Dimethylamylamine is expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 8.9 mm Hg at 25 °C(SRC), determined from a fragment constant method(2). Environmental biodegradation data specific to 1,3-dimethylamylamine were not available(SRC, 2014). However, similar aliphatic amines (such as amylamine and sec-butylamine) have been classified as readily biodegradable using the Japanese MITI test where these aliphatic am 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 200(SRC), determined from a structure estimation method(2), indicates that 1,3-dimethylamylamine may have moderate adsorption to suspended solids and sediment(SRC). Volatilization from water surfaces is expected(3) based upon an estimated Henry's Law constant of 4.2X10-5 atm-cu m/mole(SRC), developed using a fragment constant estimation method(2). Using this Henry's Law constant and an estimation method(3), volatilization half-lives for a model river and model lake are 1.1 and 11.1 days, respectively(SRC). According to a classification scheme(4), an estimated BCF of 12(SRC), from an estimated log Kow of 2.16(2) and a regression-derived equation(2), suggests the potential for bioconcentration in aquatic organisms is low. 1,3-Dimethylamylamine is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(3). Environmental biodegradation data specific to 1,3-dimethylamylamine were not available(SRC, 2014). However, similar aliphatic amines (such as amylamine and sec-butylamine) have been classified as readily biodegradable using the 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), 1,3-dimethylamylamine, which has an estimated vapor pressure of 8.9 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase 1,3-dimethylamylamine is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be about 8 hours(SRC), calculated from its rate constant of 4.9X10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(2). 1,3-Dimethylamylamine does not contain chromophores that absorb at wavelengths >290 nm(3) and, therefore, is not expected to be susceptible to direct photolysis by sunlight(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Uses: DMAA (1,3-dimethylamylamine) is an amphetamine derivative that has been widely used in sports supplements sold in the United States. Also known as methylhexanamine or geranium extract, DMAA is often touted as a "natural" stimulant, with many claimed functional uses including a body-building aid, an athletic performance enhancer, and a weight-loss aid. Although DMAA at one time was approved as a drug for nasal decongestion, no medical use of DMAA is recognized today. FDA is not aware of any reliable science indicating that DMAA exists naturally in plants. 출처: Hazardous Substances Data Bank (HSDB)
  • Uses: THERAPEUTIC CATEGORY: Adrenergic 출처: Hazardous Substances Data Bank (HSDB)
  • Uses: /Former Use/ MEDICATION 출처: Hazardous Substances Data Bank (HSDB)

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
EMBL-EBI ChEBI정확히 일치2026-08-31
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

공식 출처 및 출처 정보

등록된 출처
Great Britain Cosmetics Regulation — consolidated Annexes II–VI and amendments
출처 참조
GB Cosmetics Regulation, Annex II, entry 30
출처 기록 ID
II-30
출처 버전
2026-08-15
출처 언어
English
번역 상태
Original is English
시행일
2026-08-15
출처 업데이트
2026-08-19
스냅샷 확인
2026-08-30 04:51 UTC
검증 방법
legislation.gov.uk XML table parse; {'II': 1758, 'III': 326, 'IV': 154, 'V': 57, 'VI': 34}
SHA-256
e3a386d950f54c6e7a7f9e784d1bd46e52de725137e89d5630709824475215d8

등록된 데이터세트 주석

데이터세트 적용 범위
Complete consolidated GB Annexes II–VI, with later amendments versioned separately
권위 관련 주석
Binding GB schedules and versioned amendments to retained Regulation 1223/2009; applies to England, Wales and Scotland, not Northern Ireland
출처 라이선스
Open Government Licence v3.0 / Crown copyright
저작자 표시
Contains public sector information licensed under the Open Government Licence v3.0.

이 기록이 시장 데이터세트에서 차지하는 위치

2329
현재 Great Britain 기록
1758
Prohibited(으)로 표시된 기록
2329
이 출처 버전의 기록
2015
CAS 정체가 있는 시장 기록

상태 분포

현재 기록 2329건 중 517건에 조건 텍스트가 있습니다. 조건 필드가 비어 있는 경우 위의 기록 유형에 따라 해석되며, 제한 없는 사용에 대한 주장으로 전환되지 않습니다.

Great Britain 시장 맥락

Complete consolidated annex dataset

적용 범위 버전: GB retained Regulation 1223/2009 schedules, effective 15 August 2026

Current consolidated Annexes II–VI for England, Scotland and Wales.

확인 체크리스트

  1. Confirm INCI/CAS/EC identity.
  2. Review every current GB Annex II–VI match.
  3. Check commencement dates and later statutory instruments.
  4. Verify SCPN, responsible-person, safety-report and labelling duties.

공식 시장 출처

확인 절차 및 기록 완전성

이 결과를 규제 준수 판단에 사용하기 전에

  1. “1,3-Dimethylpentylamine and its salts”와(과) 모든 CAS/EC 식별자가 공급업체 규격서의 물질을 가리키는지 확인하세요.
  2. Confirm INCI/CAS/EC identity.
  3. Review every current GB Annex II–VI match.
  4. Check commencement dates and later statutory instruments.
  5. Verify SCPN, responsible-person, safety-report and labelling duties.
  6. 출처 버전을 기록하고, 제조, 신고 또는 시장 출시 전에 규제 기관을 다시 확인하세요.

이 기록에서 제공되는 필드

  • 공식 물질 명칭제공됨
  • CAS제공됨
  • EC제공됨
  • 별도의 조건 텍스트출처 행에 없음
  • 시행일제공됨
  • 스냅샷 해시 및 방법제공됨

이 페이지가 답하는 질문

This official record identifies the substance as prohibited for cosmetic use in the stated market scope. Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.

이 기록은 GB Cosmetics Regulation, Annex II, entry 30, 출처 버전 2026-08-15을(를) 인용합니다. 공식 출처를 여세요.

아니요. CAS는 정체를 확인하는 데 도움이 되지만, 관할권마다 같은 물질을 다르게 분류할 수 있으며 제품 범위, 한도, 경고 문구 및 경과 기간 날짜를 다르게 적용할 수 있습니다.

안정적인 인용

1,3-Dimethylpentylamine and its salts. GB Cosmetics Regulation, Annex II, entry 30. Great Britain. Source version 2026-08-15. CosIng Checker regulatory record: https://cosingchecker.com/ko/regulations/gb/records/4387/

법적 권위로서 규제 기관을 인용하세요. 이 페이지는 구조화된 근거 색인이자 확인 보조 도구이며, 공식 본문이나 전문적인 법률 평가를 대체하지 않습니다.

Great Britain의 해석 및 한계

This official record identifies the substance as prohibited for cosmetic use in the stated market scope.

Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

법적 역할 해석 방법

The cited row forms part of a binding rule or legally incorporated list for this market.

이 페이지의 근거

  • 기록된 결과: Prohibited
  • 법적 역할: Binding rule
  • 출처 버전: 2026-08-15
  • 시행일: 2026-08-15

증명하지 않는 것

No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.

추가 공신력 있는 물질 조사

이 출처들 중 어느 것도 위의 시장 판단을 번복하지 않습니다.

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

출처에서 이 정체 조사

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

출처에서 이 정체 조사

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

출처에서 이 정체 조사

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

출처에서 이 정체 조사

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

출처에서 이 정체 조사

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

출처에서 이 정체 조사

US EPA CompTox CTX APIs

가져오기에 API 키 필요

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

출처에서 이 정체 조사